Principal Scientist, ADC Technologies

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

$170K-$211K From the posting source checked Jun 20, 2026

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$55,390 U.S. median for this role

Projected growth (BLS Employment Projections)

-0.1% - Decline

244% above the BLS role benchmark for teaching and education aggregate.

Posted salary is far from this role benchmark; treat it as low confidence.

Matched to SOC 25-2021 - Teaching and Education aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Teaching Education From the posting source checked Jun 20, 2026

Seniority

Principal From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Public-company From the posting source checked Jun 20, 2026

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Principal Scientist, ADC Technologies Bothell, Washington, United States Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets. Position Overview Immunome is seeking a talented and passionate cancer biologist with experience developing and championing novel therapeutic concepts in a fast-paced scientifically rigorous environment. The person in this position will be challenged to leverage their deep understanding of cancer biology, drug resistance mechanisms, and pharmacology to engineer the next generation of ADC therapeutics. In partnership with cross-functional teams across the company, they will lead the discovery, optimization, and nomination of new drug candidates for clinical development. Responsibilities - Apply extensive knowledge of oncology and ADC pharmacology to formulate new therapeutic concepts and guide their development. - Lead preclinical discovery efforts for novel ADC technologies from linker payload discovery through target selection, therapeutic design, in vitro and in vivo characterization, optimization, candidate nomination, and IND-enabling studies. - Ensure seamless cross-functional integration with colleagues in antibody discovery, chemistry, translational sciences, program management, CMC, and clinical

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.